Burkitt Lymphoma
Relapsed/Refractory
The term “relapsed” refers to disease that reappears or grows again after a period of remission.
The term “refractory” is used to describe when the lymphoma does not respond to treatment (meaning that the cancer cells continue to grow) or when the response to treatment does not last very long.
Central Nervous System (CNS) involvement at diagnosis of Burkitt lymphoma is recognized as the strongest risk factor for relapse; therefore, recommended treatment regimens include treatment to protect the CNS, which may be given intrathecally (injected into the spinal fluid).
To learn more about primary central nervous system (CNS) lymphoma, visit the CNS Lymphoma page.
Learn More
To learn more about Burkitt lymphoma, view the Other Aggressive B-Cell Lymphoma Guide. Want to talk to someone? For answers to lymphoma-related questions and resources, contact our Lymphoma Resource Center at (800) 500-9976 or [email protected].
Additional Resources
To learn more about Burkitt lymphoma, view the Other Aggressive B-Cell Lymphomas Guide.
Events
Events
-
-
Ask the Doctor About Lymphoma: Information for Newly Diagnosed Patients
Program Overview This program provides newly diagnosed patients with a strong foundation to begin their […]
-
Update on Follicular Lymphoma Webinar
Webinars are hour-long interactive programs discussing the diagnosis and treatment of specific lymphoma subtypes and […]
-
Understanding and Accessing Chimeric Antigen Receptor (CAR) T-Cell Therapy Webinar
Program Overview Featuring Megan Melody, MDTampa General HospitalLearn more about Dr. Melody > This program […]